10-K: HealthLynked Corp. Reports Annual Results for 2024, Cites Going Concern Uncertainty

HealthLynked Corp.'s 2024 annual report reveals a net loss, decreased revenue, and raises substantial doubt about the company's ability to continue as a going concern without additional funding.

Summary

• HealthLynked Corp.'s 2024 annual report indicates a net loss of $6.13 million, a significant increase from the $1.01 million loss in 2023.
• Total revenue decreased by 47% to $3.01 million, primarily due to declines in patient service and product revenue.
• The company cites substantial doubt about its ability to continue as a going concern without additional funding, given cash balances of $76,241, a working capital deficit of $3.05 million, and an accumulated deficit of $48.16 million as of December 31, 2024.
• Patient service revenue decreased by 48% due to changes in clinical staffing and the closure of Naples Women's Center (NWC).
• Subscription revenue decreased by 45% due to a decrease in HealthLynked Network paid subscriptions.
• Product revenue decreased by 42% due to decreased marketing efforts and demand.
• Operating expenses decreased due to cost reduction efforts, but an impairment loss of $716,000 related to the NCFM Medical Database negatively impacted results.
• The company sold 5,977,193 shares of common stock for $405,000 and issued convertible notes for $3.27 million during the year.
• HealthLynked is focusing on its Digital Healthcare, Medical Distribution, and Health Services divisions.
• The company is developing its HealthLynked Network, including AI-driven features and telemedicine services.
• HealthLynked is subject to extensive healthcare regulations and faces competition from established companies.
• The company identified a material weakness in internal control over financial reporting related to the lack of documented internal control policies and procedures.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to significant losses, declining revenue, and concerns about the company's ability to continue as a going concern. While there are some positive aspects, such as cost reduction efforts, the overall tone is pessimistic from an investment perspective.

Positives

• Operating expenses decreased due to cost reduction efforts at Health Services practices and corporate offices.
• The company is focusing on its Digital Healthcare business, including AI-driven features and telemedicine services.

Negatives

• The company expresses substantial doubt about its ability to continue as a going concern without additional funding.
• Total revenue decreased by 47% to $3.01 million due to declines in patient service and product revenue.
• Patient service revenue decreased by 48% due to changes in clinical staffing and the closure of Naples Women's Center (NWC).
• An impairment loss of $716,000 was recorded related to the NCFM Medical Database.
• A material weakness in internal control over financial reporting was identified.

Risks

• The company's current cash and cash equivalents may not be sufficient to fund its business for the next twelve months.
• Failure to obtain additional financing could prevent the company from executing its business plan or operating as a going concern.
• The company faces competition from more established companies with greater financial resources.
• The healthcare industry is highly regulated, and government authorities may determine that the company has failed to comply with applicable laws, rules, or regulations.
• The company relies on Amazon Web Services (AWS) for the vast majority of its computing, storage, bandwidth, and other services, and any disruption of or interference with its use of the platform would negatively affect its operations and seriously harm its business.
• Federal and state laws that protect the privacy and security of protected health information may increase the company's costs and limit its ability to collect and use that information and subject it to penalties if it is unable to fully comply with such laws.
• The market for Internet-based personal medical information and record archiving systems may not develop substantially further or develop more slowly than the company expects, harming the growth of its business.
• The company may be sued by third parties for alleged infringement of their proprietary rights.
• The company may not be able to properly safeguard the information on the HealthLynked Network.
• The company may not be able to successfully recruit and retain qualified physicians, who are key to its Health Services segments revenues and billing.
• The company may be subject to medical malpractice and other lawsuits not covered by insurance.
• Certain federal and state laws may limit the company's effectiveness at collecting monies owed to it from patients.
• The public market for the company's common stock is limited.
• The company's common stock is subject to the penny stock rules of the SEC and the trading market in the securities is limited, which makes transactions in the company's common stock cumbersome and may reduce the value of an investment in the company's common stock.
• The company is a smaller reporting company, and it cannot be certain if the reduced reporting requirements applicable to smaller reporting companies will make its common stock less attractive to investors.
• The company's stockholders are subject to significant dilution upon the occurrence of certain events which could result in a decrease in its stock price.

Future Outlook

The company plans to profitably operate its Health Services business and continue to invest in its Digital Healthcare business, including the HealthLynked Network. The company intends to raise additional capital to fund its ongoing plan of operation.

Industry Context

The report acknowledges the highly competitive market for digital healthcare products and services, with competition from established companies like ZocDoc, AthenaHealth, and Teladoc Health, as well as major tech companies like Amazon, Google, and Apple.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or benchmarks.
• It mentions competitors like ZocDoc, AthenaHealth, and Teladoc Health, but does not offer a detailed analysis of HealthLynked's performance relative to these companies.
• The document lacks specific details on how HealthLynked's financial results compare to industry averages or best practices.

Management Changes

Related Party Transactions

• The company issued 19 new convertible notes payable to, and received three undocumented advances from, its CEO, Dr. Michael Dent, for aggregate net cash proceeds of $3,270,000 and refinanced or extended five existing notes with an aggregate principal of $866,500.
• During the years ended December 31, 2024 and 2023, the company paid Dr. Dents spouse $145,000 and $139,423, respectively, in consulting fees pursuant to a consulting agreement.
• The company's outside directors each receive compensation equal to $20,000 in shares of restricted stock per annum.

Stakeholder Impact

• Shareholders face significant dilution and potential decrease in stock price.
• Employees face uncertainty due to the company's going concern status.
• Customers may be impacted by potential changes in service offerings or business operations.
• Suppliers and creditors face increased risk due to the company's financial instability.

Next Steps

• The company plans to profitably operate its Health Services business.
• The company plans to continue to invest in its Digital Healthcare business, including the HealthLynked Network.
• The company plans to raise additional capital to fund its ongoing plan of operation.

Key Dates

Keywords

HealthLynked, Annual Report, Financial Results, Going Concern, Healthcare Technology, Digital Healthcare, Medical Distribution, Health Services, Revenue, Net Loss, Financial Performance, Risk Factors, Internal Control, SEC, Medical Records, Telemedicine, AI, Patient Care